To assess the impact of G-CSF signaling on arthritogenic alphavirus disease outcomes, we inoculated mice genetically lacking the G-CSF receptor (G-CSFR-/-) with MAYV or CHIKV. This evidence concerns the gene CSF3 and glycogen storage disease VI.